ENOV — Enovis Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Enovis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 45.8 | 76.3 | -11.8 | -32.7 | -825 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 34.2 | 56.2 | -47.8 | 5.29 | 677 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.99 | -17.1 | -222 | -27.3 | -13.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 302 | 356 | -55.9 | 135 | 114 |
| Capital Expenditures | -115 | -104 | -105 | -122 | -181 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -60.3 | -216 | -70.9 | -120 | -775 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -175 | -320 | -176 | -242 | -955 |
| Financing Cash Flow Items | -16.8 | -34.2 | 1,120 | -91.2 | -14.3 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -132 | 585 | -465 | 128 | 847 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -8.56 | 618 | -695 | 20.5 | 3.33 |